Shigeru F. Hayashi
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shigeru F. Hayashi.
Bioorganic & Medicinal Chemistry Letters | 2001
Subas M. Sakya; Melani Suarez-Contreras; John P. Dirlam; Thomas N. O'Connell; Shigeru F. Hayashi; Sheryl L. Santoro; Barbara J. Kamicker; David M. George; Carl Bernard Ziegler
3-Acetyl analogues of thiolactomycin, a thiotetronic acid natural product, were synthesized and profiled against livestock pathogens. Some analogues showed improved activity over thiolactomycin against Staphylococcus aureus and comparable activity against Pasteurella multocida. Several semisynthetically modified analogues of thiolactomycin showed no improvement in activity over thiolactomycin.
Bioorganic & Medicinal Chemistry Letters | 1997
John P. Dirlam; A. M. Belton; N.C. Birsner; R. R. Brooks; Shang-Poa Chang; R.Y. Chandrasekaran; J. Clancy; Brian J. Cronin; B. P. Dirlam; Steven M. Finegan; S. A. Froshauer; A.E. Girard; Shigeru F. Hayashi; R.J. Howe; J. C. Kane; Barbara J. Kamicker; S. A. Kaufman; Nicole L. Kolosko; M. A. Lemay; Robert Gerald Linde; J.P. Lyssikatos; C.P. MacLelland; Thomas V. Magee; M. A. Massa; S. A. Miller; Martha L. Minich; David Austen Perry; J.W. Petitpas; C.P. Reese; Scott B. Seibel
Abstract A 6a-(3′,4′-dichlorophenylamino) analog of viomycin was uncovered by a high-throughput screen against the animal health pathogen Pasteurella haemolytica, and has served as a novel lead structure for our infectious disease programs. We report herein the synthesis and activity of analogs of tuberactinomycins and capreomycin that are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci. This paper describes the synthesis and activity of some C-6a-substituted analogs of tuberactinomycins and capreomycin, which are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci.
Bioorganic & Medicinal Chemistry Letters | 1997
J.P. Lyssikatos; Shang-Poa Chang; J. Clancy; John P. Dirlam; Steven M. Finegan; A.E. Girard; Shigeru F. Hayashi; D.P. Larson; A.S. Lee; Robert Gerald Linde; C.P. MacLelland; J.W. Petitpas; Scott B. Seibel; C.B. Vu
Abstract This paper describes synthetic modifications of the C-19 position of tuberactinomycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed. Although C-19 arylation and thiolation did not improve antibacterial activity, C-19 benzyl carbamates, benzyl- and phenyl ureas were found to be more potent than the parent antibiotic.
Bioorganic & Medicinal Chemistry Letters | 2002
Hengmiao Cheng; John P. Dirlam; Carl Bernard Ziegler; Kristin Marie Lundy; Shigeru F. Hayashi; Barbara J. Kamicker; Jason K. Dutra; Kirsten L. Daniel; Sheryl L. Santoro; David M. George; Camilla D. Bertsche; Subas M. Sakya; Melani Suarez-Contreras
3,6-Ketals of 15-membered azalide pseudoaglycones are a novel series of macrolide antibiotics. The aromatic derivatives of the azalide 3,6-ketals demonstrated potent antibacterial activities against both Gram-positive and Gram-negative bacteria.
Bioorganic & Medicinal Chemistry Letters | 2003
Subas M. Sakya; Peter Bertinato; Bryan Pratt; Melani Suarez-Contreras; Kristin Marie Lundy; Martha L. Minich; Hengmiao Cheng; Carl Bernard Ziegler; Barbara J. Kamicker; Shigeru F. Hayashi; Sheryl L. Santoro; David M. George; Camilla D. Bertsche
Aryl and hetero aryl substituted 3,6-ketals of 15-membered azalide analogues were synthesized and were found to have potent in vitro antibacterial activity against veterinary pathogens, including Staphylococcus aureus and Pasteurella multocida.
Journal of Medicinal Chemistry | 1997
James W. McFarland; Cynthia M. Berger; Susan Froshauer; Shigeru F. Hayashi; Scott J. Hecker; Burton H. Jaynes; Martin Raymond Jefson; Barbara J. Kamicker; Christopher A. Lipinski; Kristin Marie Lundy; Catherine P. Reese; Chi B. Vu
Bioorganic & Medicinal Chemistry Letters | 2002
Michael A. Letavic; Brian Scott Bronk; Camilla D. Bertsche; Jeffrey M. Casavant; Hengmiao Cheng; Kirsten L. Daniel; David M. George; Shigeru F. Hayashi; Barbara J. Kamicker; Nicole L. Kolosko; Laura J. L. Norcia; Vanessa D. Oberton; Margaret Rushing; Sheryl L. Santoro
The Journal of Antibiotics | 1997
Shigeru F. Hayashi; Laura J. L. Norcia; Scott B. Seibel; Annette M. Silvia
The Journal of Antibiotics | 2004
Laura J. L. Norcia; Annette M. Silvia; Sheryl L. Santoro; Jim Retsema; Michael A. Letavic; Brian Scott Bronk; Kristin Marie Lundy; Bingwei Yang; Nigel A. Evans; Shigeru F. Hayashi
The Journal of Antibiotics | 1999
Laura J. L. Norcia; Annette M. Silvia; Shigeru F. Hayashi